LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.4700
-0.0100 (-2.08%)
Oct 1, 2026, 4:10 PM AEST
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 85.44 million as of October 1, 2026. Its market cap has decreased by -25.92% in one year.
Market Cap
85.44M
Enterprise Value
65.77M
Revenue
723.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.47
ChartMarket Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 85.44M, an increase of 61.26%. That is a compound annual growth rate of 18.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 85.44M | -34.67% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 138.09M |
| Island Pharmaceuticals | 116.89M |
| Nyrada | 115.13M |
| Recce Pharmaceuticals | 99.38M |
| Alterity Therapeutics | 88.28M |
| Prescient Therapeutics | 75.71M |
| Avecho Biotechnology | 73.41M |
| Entropy Neurodynamics | 65.34M |